1H25阳光人寿NBV可比口径下同比+47.3%至40.1亿元，其中个险/银保分别同比+23.5%/+53%;今年实际 披露NBV比去年实际披露同比+7.0%，调整后/调整前仍实现增长，好于该行预期;寿险CSM余额560.8亿 元，较上年末增长10.3%。分渠道看，个险渠道"浮动收益型+保障型产品"占比超50%;银保渠道"浮动收 益型+保障型产品"占比27.1%，分红险转型下产品结构优化明显。 财险承保盈利同比改善 1H25阳光财险原保险保费同比增长2.5%至252.7亿元，其中非车险分别同比+12.5%，非车险保费占比 50.6%，同比提升4.5ppt;CoR同比-0.3ppt至98.8%，其中赔付率/费用率分别同比+2.5ppt/-2.8ppt;车险CoR 同比-1.6ppt至98.1%，车险中家用车保费占比提升3ppt，新能源车险保费占比提升2.1ppt。 智通财经APP获悉，中金发布研报称，阳光保险(06963)当前交易于0.38x/0.33x 2025e和2026e P/EV，维 持公司2025-2026年盈利预测基本不变，维持目标价4.60港币和跑赢行业评级，对应0.40x/0.34x 2025e ...

Investment Rating - The investment rating for the company is "Outperform the Market" [6][10]. Core Views - The company has optimized its liability structure, leading to an increase in profit levels despite a decline in total revenue due to market conditions [1][3]. - The company has increased its premium income by 5.0% year-on-year, outperforming the industry, through a focus on high-quality product offerings and differentiated sales strategies [2]. - Investment income has been under pressure due to market volatility, with total investment income decreasing by 17.2% year-on-year [3]. Revenue and Profit Performance - In Q1 2025, total revenue decreased by 8.9% year-on-year, while net profit attributable to shareholders increased by 39.5% to 28.802 billion yuan [1]. - The company achieved total premium income of 354.41 billion yuan in Q1 2025, with renewal premiums growing by 9.7% and new premiums declining by 4.5% [2]. Investment Income and Asset Management - Total investment income for Q1 2025 was 53.767 billion yuan, with a total investment return rate of 2.75%, down from 3.23% in the same period of 2024 [3]. - The company has increased the proportion of floating income products, with first-year premiums from floating income products accounting for 51.7% of total first-year premiums [2]. Financial Forecasts - The company forecasts earnings per share (EPS) of 3.83, 3.88, and 3.94 yuan for 2025, 2026, and 2027 respectively, with a current price-to-embedded value (P/EV) of 0.69, 0.64, and 0.58 for the same years [3][5].

Investment Rating - The report maintains a "Recommended" rating for China Life Insurance (601628) with a target price of 51.7 CNY [2]. Core Views - In Q1 2025, the company achieved a net profit attributable to shareholders of 28.8 billion CNY, representing a year-on-year increase of 39.5%. The new business value (NBV) grew by 4.8% year-on-year, while net and total investment returns were 2.6% and 2.75%, respectively, down by 0.22 percentage points and 0.48 percentage points year-on-year [2][7]. - The company is experiencing significant growth in performance compared to its peers in the life insurance sector, primarily due to a substantial decrease in insurance service costs [7]. - The transformation of product offerings is showing clear results, with floating income products accounting for 52% of first-year premium income, a significant increase year-on-year. This shift is expected to help mitigate the cost pressures associated with guaranteed returns [7][8]. Financial Summary - **Revenue and Profit Forecasts**: - Revenue (million CNY): 2024: 528,567; 2025E: 502,046; 2026E: 510,364; 2027E: 514,581 [8]. - Net Profit (million CNY): 2024: 106,935; 2025E: 87,430; 2026E: 90,028; 2027E: 91,854 [8]. - Earnings per Share (CNY): 2024: 3.78; 2025E: 3.09; 2026E: 3.19; 2027E: 3.25 [8]. - **Valuation Ratios**: - Price-to-Earnings Ratio (P/E): 2025E: 12.2; 2026E: 11.9; 2027E: 11.6 [8]. - Price-to-Book Ratio (P/B): 2025E: 2.0; 2026E: 2.0; 2027E: 2.0 [8]. Investment Insights - The company’s investment assets reached 6.82 trillion CNY by the end of Q1 2025, reflecting a 3.1% increase from the end of the previous year. Despite fluctuations in interest rates, the company’s net investment yield decreased, primarily due to the expiration of high-yield fixed-income products [7][8]. - The report anticipates that the company's performance will improve in Q2 2025 as interest rates decline, potentially alleviating some of the negative impacts from floating losses on bonds [7].

Investment Rating - The investment rating for China Life Insurance is "Buy" [8] Core Insights - In Q1 2025, China Life's net profit attributable to shareholders reached 28.802 billion yuan, a year-on-year increase of 39.5%, exceeding expectations primarily due to a significant reduction in insurance service expenses [1] - The company's operating revenue was 110.177 billion yuan, down 8.9% year-on-year, while the weighted ROE was 5.53%, an increase of 1.22 percentage points year-on-year [1] - The new business value (NBV) showed a slight growth of 4.8% year-on-year, which was slightly below expectations [1][2] Summary by Sections Performance Overview - In Q1 2025, China Life's net profit was 28.802 billion yuan, a 39.5% increase year-on-year, driven by a significant decrease in insurance service expenses [1] - Operating revenue decreased to 110.177 billion yuan, down 8.9% year-on-year [1] - The weighted ROE improved to 5.53%, up 1.22 percentage points year-on-year [1] New Business Value (NBV) - The NBV experienced a slight increase, primarily attributed to a small improvement in the new business value rate [2] - New single premium income was 107.434 billion yuan, a decrease of 4.5% year-on-year, with a strong push for the sale of floating income products, which accounted for 51.72% of the first-year premium income, a significant increase year-on-year [2] Agent Workforce - As of the end of Q1 2025, the number of individual insurance agents was 596,000, a decrease of 3.1% compared to the end of the previous year, maintaining overall stability [3] - The quality of the workforce improved, with effective increases in the agent retention rate and growth rate [3] - The new marketing model "Seed Plan" is being implemented, focusing on professionalization and comprehensive transformation of the sales team [3] Investment Performance - As of the end of Q1 2025, China Life's investment assets totaled 6.82 trillion yuan, an increase of 3.1% from the end of the previous year [4] - Total investment income was 53.767 billion yuan, a year-on-year decrease of 16.8%, with annualized net investment yield and total investment yield at 2.6% and 2.75%, respectively [4] Profit Forecast and Valuation - The company expects stable growth in NBV, supported by a stable workforce and enhanced productivity, with contributions from the bancassurance channel anticipated to increase [5] - The forecasted net profit growth rates for 2025-2027 are -60.5%, 13.5%, and 29.3%, respectively [5] - The target price is set at 56.63 yuan, corresponding to a PEV of 1.0 times for 2025 [5]

Core Viewpoint - China Life Insurance aims to become a global leader in the life insurance industry by enhancing its core capabilities and maintaining a strong focus on innovation and customer service [1][3][5]. Financial Performance - In 2024, China Life's total premium reached 671.46 billion yuan, with first-year premiums hitting a record high of 119.08 billion yuan [1]. - The company's embedded value exceeded 1.4 trillion yuan, and the new business value for the year was 33.71 billion yuan, leading the industry [1]. - Total investment income amounted to 308.25 billion yuan, reflecting a significant year-on-year increase of 150%, with net profit attributable to shareholders rising by 108.9% to 106.93 billion yuan [1]. Strategic Goals - The company plans to strengthen five key capabilities: risk protection, asset-liability linkage, value creation, risk control, and global asset allocation [3][4]. - China Life aims to enhance its service offerings and product diversity, focusing on customer needs across different life stages [5][6]. Product Development - As of the end of 2024, the personal pension business reached nearly 3 billion yuan, with over 270,000 policies serviced, making it the industry leader [5]. - The company has launched over 500 health insurance products since 1999, with 220 currently available, and aims to expand its health insurance offerings further [6]. Investment Strategy - China Life's investment strategy emphasizes long-termism, focusing on stable asset-liability matching and value investing [7]. - The company has a total investment scale exceeding 4.8 trillion yuan, with a total investment return rate of 5.50% [6]. Shareholder Returns - In 2024, China Life implemented its first interim dividend, with total dividends reaching 18.37 billion yuan, a 51% increase from 2023 [10][11]. - The company plans to maintain a high dividend payout while balancing shareholder interests and sustainable development [11].